From: Analysis of related factors for neuropsychiatric comorbidities in children with epilepsy
Genetic causes | n |
---|---|
Tuberous sclerosis (TSC gene mutation) | 3 |
Angel syndrome/pradar-Willi syndrome (UBE3A gene heterozygous deletion) | 2 |
Dravet syndrome (SCN1A gene mutation) | 2 |
Infantile epilepstic spasms syndrome (IESS) (trisomy 21, ARX gene mutation, CDKL5 gene mutation, STXBP1 gene mutation, IQSEC2 gene mutation, TSC1 gene mutation, and TSC2 gene mutation) | 7 |
Trisomy 21 syndrome (karyotype analysis: 47, XY + 21) | 1 |
Methylmalonic acidemia with hyper homocysteinemia | 2 |
Y chromosome long arm deletion (deletion greater than 3372 Kb of Y chromosome long arm) | 1 |
Karyotype analysis: 46, XY (Y is equivalent to 18) | 1 |
SCN1A gene mutation (unclear clinical phenotype) | 1 |
SCN2A gene mutation | 1 |
SCN8A gene mutation | 1 |
KCNO2 gene mutation | 3 |
FASN gene mutation | 1 |
PRRT2 gene mutation | 1 |
KCNT1 gene mutation | 1 |
PARS2 gene mutation | 1 |
GRIN2B gene mutation | 1 |
RHOBTB2 gene mutation | 1 |
CDKL5 gene mutation | 1 |
PCDH19 gene mutation | 1 |
GABRB3 gene mutation | 1 |
GABRA1 gene mutation | 1 |
STXBP1 gene mutation | 1 |
SLC35A2 gene mutation | 1 |
UBA5 gene mutation | 1 |
PACS1 gene mutation | 1 |
ARID1B gene mutation | 1 |
BRANBP2 gene mutation | 1 |
ANKRD11, NOTCH1 gene mutation | 1 |